NCT02505438

Brief Summary

Maintaining muscle mass and function is important in healthy ageing to maintain quality of life. Loss of muscle mass is major problem, as beyond the age \~50, muscle mass declines by \~1-2% a year. To prevent this loss, the investigators need to understand the mechanism regulating muscle mass as we age. In this project the investigators aim to determine these mechanisms using a new technique of heavy water ingestion, this allows measurement of multiple aspects of skeletal muscle mass metabolism e.g. protein synthesis, over long periods (6 weeks) as people go about their normal everyday activities. The investigators also aim to determine the influence of resistance exercise training on older muscle, as well as differences between men and women in muscle responses to exercise and nutrition HMB (beta-hydroxy-beta-methylbutyrate).

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P50-P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2013

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

May 8, 2015

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 22, 2015

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Last Updated

December 9, 2015

Status Verified

December 1, 2015

Enrollment Period

2.7 years

First QC Date

May 8, 2015

Last Update Submit

December 8, 2015

Conditions

Outcome Measures

Primary Outcomes (2)

  • Muscle Protein Synthesis

    Comparison of muscle protein synthesis between young and older individuals and in response to 6 weeks unilateral exercise training and supplementation

    0-6 Weeks

  • Muscle Strength

    Maximal voluntary contractions of the quadriceps will be performed (leg extension) in the trained and untrained legs. This will be performed at baseline and repeated throughout to monitor training progression

    0-6 Weeks

Study Arms (4)

Young Unilateral Exercise

EXPERIMENTAL

Young Individuals (18-30y) studied before and after 6 weeks unilateral resistance exercise training

Behavioral: Exercise

Old Unilateral Exercise

EXPERIMENTAL

Old individuals (65-75y) studied before and after 6 weeks of unilateral resistance exercise training

Behavioral: Exercise

Old Unilateral Exercise and HMB

EXPERIMENTAL

Old individuals (65-75y) studied before and after 6 weeks of unilateral resistance exercise training with HMB (beta-hydroxy-beta-methylbutyrate) supplementation

Behavioral: Exercise

Old Unilateral Exercise and Omega 3

EXPERIMENTAL

Old individuals (65-75y) studied before and after 6 weeks of unilateral resistance exercise training with Omega 3 supplementation

Behavioral: Exercise

Interventions

ExerciseBEHAVIORAL
Old Unilateral ExerciseOld Unilateral Exercise and HMBOld Unilateral Exercise and Omega 3Young Unilateral Exercise

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Young (18-30y) and old (60-75y) individuals who are generally healthy and recreationally active

You may not qualify if:

  • Active cardiovascular disease
  • Cerebrovascular disease including previous stroke, aneurysm (large vessel or intracranial)
  • Respiratory disease including pulmonary hypertension or Chronic obstructive pulmonary disease, Hyper/ hypo parathyroidism, hyper/ hypothyroidism,
  • Cushing's disease, diabetes
  • Active inflammatory bowel disease
  • Renal disease
  • Malignancy
  • Recent steroid treatment (within 6 mo), or hormone replacement therapy Clotting dysfunction
  • Musculoskeletal or neurological disorders
  • Any disease requiring long-term drug prescriptions, including statins

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Derby Hospital Medical School

Derby, DE22 3DT, United Kingdom

RECRUITING

MeSH Terms

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Ken Smith, PhD

    University of Nottingham

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ken Smith, PhD

CONTACT

Matthew Brook

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 8, 2015

First Posted

July 22, 2015

Study Start

April 1, 2013

Primary Completion

December 1, 2015

Last Updated

December 9, 2015

Record last verified: 2015-12

Locations